Good Clinical Practice (GCP) Audits: Best Practices for Ensuring Compliance and Detecting Fraud and Misconduct in Clinical Trials

  • A white background with a few lines on it

    Slide title

    "This is one of the best courses I have ever taken. The Course Director was very clear and straight to the point. The content was up to date and full of real-life examples!"


    Marilia B., Compliance & Training Manager, Roche Brazil

  • A white background with a few lines on it

    Slide title

    "The small class allowed for great class discussion. Course Director was VERY KNOWLEDGEABLE on the topic. He was able to address all questions."


    Karen W., Senior Scientific Compliance Scientist, AbbVie

  • A white background with a few lines on it

    Slide title

    "The Course Director gave many practical, real life examples on dealing with and detecting fraud and misconduct. He was very knowledgeable and engaging." 


    John D., Quality Assurance Auditor, Johnson & Johnson

  • A white background with a few lines on it

    "The course was very well presented, and it was not rushed. The information was detailed and flowed well. The course content was supported by real examples."  


    Sanjay M., Global Director of Quality Systems, NAMSA

Next Course

15-Hour Live Stream or On-Site

2026 Course Dates will be available soon. Please join the wait list or if you have more than 10 who need training we can provide on-site course customization and delivery details.

Join The Wait List Request On-Site Details
A man in a suit and tie with a plus sign on his chest.

Course Director

A dollar sign in a circle on a white background.

Course Fee

$2150.00 Regular Registration

$1950.00 Early Bird Pricing (Register 30 Days in Advance)

A black and white icon of a calendar on a white background.

Future Live Stream Sessions (click to register)

GCP Audits: Best Practices for Ensuring Compliance and Detecting Fraud and Misconduct in Clinical Trials Course Description

This 15 hour GCP training course provides a solid understanding of GCP requirements and clinical quality assurance in detecting fraud and misconduct in clinical trials. Attendees will gain experience in detecting, correcting and preventing clinical study misconduct and fraud at domestic and international clinical sites.


Additionally, attendees will learn how to ensure that their study conduct and supporting documentation is accurate and factual. The course will also address uncovering misconduct, handling its consequences and identifying proactive solutions to prevent further problems. Included in the coursework are practical examples and a roadmap for evaluating study conduct, source documents, case report forms and other study documentation through presentation and interactive case studies.


Additionally, the course will cover methods to detect misconduct and deal with fraud in clinical trials by:


  • Defining the basic requirements of GCP.
  • Determining the appropriate duties and oversight required of the sponsor, monitor and investigators, to ensure a high level of quality in a clinical trial.
  • Ensuring that quality practices are designed and implemented to guarantee compliant clinical trials.
  • Learning how to effectively manage a Sponsor and a Food and Drug Administration (FDA) GCP inspection.
  • Developing mechanisms to uncover and preclude fraud and misconduct in clinical trials.
  • Building trial guidelines and structure to easily identify any misconduct, which can quickly address issues that arise in order to avoid regulatory consequences.


This International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6 GCP Investigator Site Training meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma Inc. as necessary to enable mutual recognition of GCP training among trial sponsors.

Who Should Attend This GCP Compliance Monitoring Course?

A GCP audit can lead to the detection of problems with the conduct of the clinical trial. It is important to understand differences between a lack of knowledge and poor execution versus actual misconduct and fraud. This two-day course will discuss some of the common issues in clinical trials, how to handle problem findings and how to distinguish between poor performance and misconduct.


This GCP training course will benefit those involved in the monitoring or questioning of clinical trials. Attendees who are involved with the supervision or oversight of clinical trial practices and quality will find this course to be highly beneficial.

Join The Wait List Request On-Site Details

  • Learning Objectives

    Upon completion, attendees will be able to:

    • Identify and define the principles and requirements for GCPs.
    • Define the basic roles and responsibilities of the sponsor, monitor, investigators and FDA as they relate to the quality of clinical trials.
    • Understand the GCP audit process for sponsors.
    • Know when to conduct audits of vendors, sites, IRBs and laboratories.
    • Ensure that your data and supporting documentation are accurate and presentable for inspection.
    • Gain knowledge concerning common outcomes and findings in clinical trials.
    • Understand how to respond to an audit to avoid further regulatory consequences.
    • Learn how to detect and prevent fraud and misconduct in clinical trials.
    • Fully understand the consequences that result when proper procedures are not followed, through the use of examples.

    Case study analysis, exercises and videos will be used throughout the course to provide insight and promote discussion.

  • Agenda

    Learn what this investigator site audit training will cover.


    Session 1: Defining the Basic Requirements of GCP

    The course director will start this program with:

    • Terminology
    • An overview of clinical compliance laws
    • FDA, ICH, ISO and global requirements
    • Understanding the role of the FDA, Office for Human Research Protections (OHRP) and Institutional Review Boards (IRBs)
    • How the GCP guidelines help in good studies
    • Understanding the roles and responsibilities of the clinical research team
    • Group discussion of interpreting regulatory requirements for GCP

    Session 2: Industry Overview – FDA Regulatory Requirements – Are You Ready for an FDA Inspection?

    Learn if you're ready for an inspection by:

    • Understanding regulatory obligations
    • Identifying key documents
    • Differences and similarities for drugs and device audits
    • Compliance issues

    Session 3: The Different Types of Audits

    Our program covers data integrity in clinical research, including:

    • When and why to audit
    • Who and what is inspected
    • Audit problems and issues
    • What to avoid
    • Data quality and integrity issues & solutions

    Session 4: Role of Monitoring in Detecting Misconduct

    We discuss clinical trial audit techniques, including:

    • Defining the difference between auditing and monitoring
    • What are the big items that must be in place
    • Common problems
    • Knowing what questions to ask in monitoring a site
    • Pointing out site performance deficiencies
    • Identifying solutions to deficiencies
    • What to do if misconduct is suspected

    Session 5: Conducting GCP Audits

    Participants will learn:

    • Different types of audits
    • Key activities during an audit
    • What to expect and common findings
    • Audit reports and follow-up

    Session 6: FDA BIMO Inspections

    This course covers essentials, such as:

    • Preparing for the visit
    • Source documentation
    • Common GCP deficiencies
    • Recent BIMO results
    • Review potential roadblocks of noncompliance
    • Identifying potential problems early

    Session 7: Preventing Fraud and Scientific Misconduct

    We discuss the risks of clinical trial fraud detection, including:

    • Maintaining accurate records
    • How to detect fraud in case report forms and clinical trial materials
    • Misleading data and results
    • Examples of fraud

    Session 8: Non-FDA audits

    Participants will become familiar with:

    • Identifying other groups
    • Roles in the detection of fraud and misconduct
    • Interactions with the FDA

    Session 9: Case Examples of Misconduct and Fraud

    This course shares:

    • Key findings from recent cases
    • Types of problems and possible preventive actions

  • Testimonials

    Review what attendees say about this training program.


    "Instructor was extremely knowledgeable and presented in a way that kept my attention despite work distractions. I appreciated the industry examples provided."

    Danielle P., Manager, Quality Systems, NAMSA


    "The course was very well presented, and it was not rushed. The information was detailed and flowed well. The course content was supported by real examples."

    Sanjay M., Global Director of Quality Systems, NAMSA


    "The Program content was informative and useful for GCP concepts and the Course Director was very knowledgeable and interactive."

    Archana P., QA Manager, SK Lifescience


    "This was my first training course and I loved it! I enjoyed the examples of misconduct to show how the systems in place operate when bad research is conducted."

    Andrew, Compliance Officer, UCLA


    "A great instructor!! I truly learned a lot, and he kept us all very engaged."

    Andrea D., CRA, Medtronic


    "The small class allowed for great class discussion. Course Director was VERY KNOWLEDGEABLE on the topic. He was able to address all questions."

    Karen W., Senior Scientific Compliance Scientist, AbbVie


    "This is one of the best courses I have ever taken. The Course Director was very clear and straight to the point. The content was up to date and full of real-life examples!"

    Marilia B., Compliance & Training Manager, Roche Brazil


    "Although some of the material was a review for me, I felt it was presented very well. The instructor kept the course interesting through discussions and interactions with attendees."

    John V., Clinical Program Manager, Sorin Group


    "The Course Director gave many practical, real life examples on dealing with and detecting fraud and misconduct. He was very knowledgeable and engaging."

    John D., Quality Assurance Auditor, Johnson & Johnson

FAQs

  • Who are "non-microbiologists"?

    A non-microbiologist is anyone who has never taken a course in present-day microbiology or who has taken a course in microbiology a long time ago. The level of this course is suitable for anyone who has had a high school education. For participants who have had previous college-level courses in microbiology, the course may be a review with the addition of the results of new research. The course is updated with the results of new research each time it is given.

  • I have no formal training in science at any level; will I be able to understand the subject matter in this course?

    Yes. Microbiology is a very descriptive science and the basic concepts are not difficult to understand. The course starts by establishing a background for understanding the biology of microorganisms and then proceeds to apply this background to the practical problem of keeping cleanrooms and products produced in cleanrooms free of microorganisms.

  • What microbiology subjects are covered?

    After a discussion of the general features of microbials, the course deals with the common contaminants of cleanrooms: bacteria, bacterial spores, bacterial dormant states, biofilms, mycoplasmas and fungi. Principles and methods for estimating bacterial populations in cleanrooms are discussed.

  • What cleanroom topics are covered?

    Major topics that are covered include; airflow in cleanrooms, sources of microbial contamination, non-microbial airborne particle counting, airborne microbial counting, surface cleaning for removal of microbial contamination, determination of surface microbial contamination, and basic validation of microbial removal. There is also a discussion of emerging methods in preventing, removing, and quantitating microbial contamination

  • How much are cGMP governmental standards and regulations covered?

    Current US and EU standards for non-viable particle and microbial airborne and surface contamination are presented. However, this is not a course where detailed cGMP regulations and auditing are presented and discussed in depth.

  • Will someone from the medical device industry profit from this course?

    Yes. While the standards and regulations for allowable amounts of microbial contamination in medical devices are different and more complex than those for parenteral drugs, the problems of keeping environments where medical devices are manufactured free from microbial contamination are very similar and often identical to the same problems in drug production.

  • Will someone involved in aseptic processing profit from this course?

    Yes. Minimizing microbial contamination in aseptic production cleanrooms is especially important.

Registrant Information:

Each person attending a course will be asked to set up an Attendee Profile Account during the registration process. Creating an Account helps you view your order history and manage your training programs. If you are registering for others, please set up an Account in the Attendee’s name. If you are registering more than one person, you’ll need to set up a separate account for each Attendee.